INCY
#511
Incyte Corporation - Common Stock
127.7 4 USD
0.00%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.30%
Variación mensual
-0.88%
Variación en los últimos 6 meses
+27.82%
Cambio anual
+52.34%
Cierres anteriores
128.1 2
Open
127.7 4
Mínimo
127.7 4
Máximo
127.7 4
Volumen
169
Financials
- Market Capitalization 25.89 B
- Employee 2 844
- Founded 2002
- CEO Hervé Hoppenot
- Website www.incyte.com
- Headquarter Delaware, United States
- FIGI BBG000BNPSQ9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
15.41
Relación precio/flujo de caja
3.86
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 497 |  BNTX BioNTech SE - American Depositary Shares | 111.40 USD | -1.03% | +0.43% | +20.56% | +9.51% | 26.73 B USD | ||
| 501 |  INSM Insmed Incorporated - Common Stock | 121.39 USD | -2.41% | -2.91% | +16.74% | -25.09% | 26.51 B USD | ||
| 564 |  UTHR United Therapeutics Corporation - Common Stock | 527.91 USD | +2.17% | +0.89% | +0.35% | +71.87% | 22.64 B USD | ||
| 675 |  JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 251.10 USD | +0.73% | +0.94% | -2.39% | +79.36% | 16.30 B USD |